News

April 8, 2016

SAN DIEGO, January 31, 2012 – BioTox Sciences is pleased to share that their most recent FDA audit was met with no deviations from the regulations. No observations, 483's or findings were noted in the three and a half day inspection.

San Francisco, March 11-15, 2012 – BioTox Sciences attends the SOT's Annual Meeting and Toxicology Expo at the Moscone Convention Center in San Francisco, California. The Annual Meeting is the premier event in the Toxicology community that addresses the latest achievements in Toxicology that have been accomplished within the last year.

CHICAGO, March 31, 2012 – BioTox Sciences attends the American Association for Cancer Research Annual Meeting in Chicago, Illinois. The American Association for Cancer Research Annual Meeting serves as the culmination of all new advancements and findings from all major areas of cancer research from the past year.

SAN DIEGO, APRIL 17-19, 2012 – BioTox Sciences attends the Cambridge Healthtech Institue's Seventh Annual Drug Discovery Chemistry at Hilton San Diego Resort & Spa.

SAN DIEGO, MAY 14, 2012 – Following the acquisition of Bio-Quant, Inc., BioTox Sciences is pleased to announce the successful merger of all accreditations.

SAN DIEGO, JUNE 18, 2012 – BioTox Sciences operates two vivaria (21,000 sq ft and 12,500 sq ft) that provide the following benefits: Small and large housing rooms, AAALAC compliant air exchanges temperature and humidity controls, Temperature and light cycle can be adjusted for individual rooms, Secure pass code access unique to each room using The Edstrom Watch Dog System, Automated bottle, cage and racks cleaning cycle, Highly skilled and trained staff available for any technical assistance needed.

SAN DIEGO, OCTOBER 16, 2012 – BioTox Sciences launches its new website. A refined and valuable resource for your Discovery to IND Preclinical needs.

SAN ANTONIO, MARCH 10-14, 2013 – BioTox Sciences to participate in the 2013 SOT to be held in San Antonio, Texas at The Henry Gonzales Convention Center.

See why we’ve been trusted to support ### IND & IDE submissions

  • GLP, IND-enabling studies
  • Huge portfolio of species and models, including NHP, for maximum translational relevance
  • "Extra mile” service and support
  • Extensive bioanalytical capabilities
  • Rapid study initiation - usually 2 weeks or less!